News Archive - 2008

Bio Nano Consulting (BNC), the specialist bionanotechnology product development consultancy, announced at Genesis 2008 in London that it has just completed its second major project for US-based pharmaceutical company, Targanta Therapeutics Corporation. BNC has used its position as world-leaders in cantilever-array assay systems to analyse in greater detail the mechanism of action of Targanta’s lead antibiotic, oritavancin, a novel lipoglycopeptide antibiotic.

This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at UCL are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. The researchers, led by Dr Rachel McKendry and Professor Gabriel Aeppli, developed ultra-sensitive probes capable of providing new insight into how antibiotics work, paving the way for the development of more effective new drugs.

Bio Nano Consulting (BNC), the specialist bionanotechnology product development consultancy, has appointed Mike Fisher PhD as Business Development Director and to manage a major new UK Government contract. Until recently Dr Fisher was with UKTI in Boston, USA as the British Government’s North American advisor on life sciences.

BNC and Oxford Immunotec work together to improve infectious disease diagnosis and monitoring. Bio Nano Consulting (BNC), the specialist bio-nanotechnology product development consultancy, today announced that it has commenced a project with international T cell measurement company, Oxford Immunotec. BNC is applying its expertise in nano-characterisation to assist Oxford Immunotec in a project related to its novel Enzyme-Linked ImmunoSPOT (ELISPOT) system. As specialists in bio-nanotechnology, BNC is able to utilise the world-leading nano-characterisation facilities at the Institute of Biomedical Engineering, Imperial College London.

Commissioning of new tool allows Bio Nano Consulting to offer advanced system for prototyping on the micron scale. Bio Nano Consulting (BNC) is pleased to announce the availability of its latest tool for advanced prototyping with the commissioning of a new laser micro-machining system. The Oxford Lasers E-series system is an ideal tool for micro-drilling, micro-cutting and micro-milling of almost any solid material with an extremely high degree of accuracy.

A significant step forward in the practical delivery of nanotech for biomedical applications was taken last night with the official launch of Bio Nano Consulting. Formerly known as the Bio Nano Centre, the new Bio Nano Consulting (BNC) is a specialist product development consultancy applying nanotechnology tools to address real-world problems from the biomedical industry. Established in late 2007, BNC provides a seamless concept-to-market route for the bio- nanotechnology sector, and already has two projects underway with major pharmaceutical and diagnostics companies.

The Bio Nano Centre (BNC) today announced that it has commenced its first commercial project with a major pharmaceutical client. The London-based specialist research and development consultancy is using its position as world-leaders in cantilever-array assay systems to analyse in greater detail the mechanism of action of oritavancin, a novel lipoglycopeptide antibiotic under development at US-based Targanta Therapeutics Corporation. This project builds on the BNC’s experience with other antibiotics.